A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating ...

CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

Pat Crotty, VFI CEO, said in a statement: “Publicans are being squeezed from every angle—rising energy costs, higher wages ...

Sonic has launched a new menu called its Daily Cravings & Savings. It offers food enthusiasts, a wide chance to feast on ...

A mom said that she and her teenage daughter were treated to breakfast by her “frugal” father only to later be berated by him ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...

The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device ...

As the city of Pittsburgh and Allegheny County prepare for more snowfall into Thursday, residents in hilly, still ...

Needham upgraded its price target for Bitdeer by 57 percent to $22 from $14, while giving it a “buy” rating, indicating an ...